Sougato Das

I am an accomplished pharmaceutical IT product manager and business analyst, experienced in biopharma business development, clinical development and operations, regulatory, pharmacovigilance, medical affairs and marketing.

President & COO

Life Science Nation (LSN), Boston Q2 2024 - Present

LSN provides the RESI partnering conferences, investor, pipeline and deals databases, entrepreneurial education, and investor meeting arrangement in the world of biotech investment & BD.

I lead the operations of the company, including marketing, investor, deals & pipeline database development & editorial, IT, customer service, event planning, and India outsourcing. Databases are commercialized as Biotechgate and the LSN Investor Database, and power the RESI partnering system, investor meeting arrangement services and AI-powered pitch deck preparation services.

Since I started as COO, LSN revenue grew 25% in the first year and is on track to grow another 25% this year. Prior, revenue was flat for 3 years. I manage a team of 15.

General Manager, Biotech Partnering & Data

Inpart (formerly Inova), Lyon, France Q3 2022 – Q1 2024

Inpart provides the business development CRM used by most large pharma BD departments, BIO’s partnering system (also used by other partnering conferences), and a tech transfer marketplace.

I led the biotech partnering & data unit, responsible for product management/ development, sales, marketing, finance, customer service, editorial, and India outsourcing. I commercialized BIO’s partnering system, integrated with Cortellis, to numerous other conference providers including LSX, Advanced Therapies Week, and Biocom. I also led the data integration and AI initiatives that took intelligence from the partnering system and integrated it into Inpart’s BD CRM to provide fast access to competitive intelligence in the pharma BD workflow.

I managed a team of 10.

BIO 2022 Management Consultant, Marketing

Biotechnology Innovation Organization (BIO), Washington, D.C. Q1 2022 – Q3 2022

With BIO’s former marketing team of 13 made redundant and 2 new hires experienced in neither biotech nor event marketing, BIO management worried BIO 2022, one of the first major ‘post-Covid’ in-person events, would underperform. I was asked to lead marketing for the event based on my previous history at BIO.

• Created and executed marketing campaigns across email, LinkedIn and paid advertising aimed at large pharma and biotechs.
• Devised new and extremely effective marketing strategies still used by BIO today and adopted by BIO competitors such as Informa. Examples include investor/in-licensor webinars, distribution of large pharma ‘contact cards’, and a mobile app listing JPM receptions.
• Provided analytics post-BIO to show marketing impacts on a successful return to live partnering.
• Managed large pharma partnering campaigns including those of Merck, J&J, Sanofi, Lilly, Pfizer and others, which included direct interactions with VP and SVP level.

Executive Vice President & Co-founder

Prism Science (now part of Cellix Bio), New York, NY Q3 2019 – Q1 2022

Prism Science, now merged with Cellix Bio, provided intelligence to large pharma R&D, medical affairs and pharmacovigilance. Additionally, it provided advertising solutions to large pharma commercial.

I functioned as a COO, leading all functions except sales and finance.

Prism

Science gathered a tremendous amount of biomedical intelligence, indexed it to leading ontologies, curated it both manually and via machine learning, and commercialized it as SaaS offerings and services. Information was gathered annually from 50+ citation indexes, 10K+ biomedical conferences, 300+ grant databases, 40+ clinical trial registries and 15+ pre-print servers. Patents were licensed from IFI Claims.

Prism

Science was on the path to provide the largest database of biomedical research output in existence, surpassing Embase, WoS and others. Content was productized as a search engine, a pipeline database, a KOL identification and profiling solution, and a ML-powered literature monitoring solution. Content was also leveraged to do bespoke medical affairs projects on share of voice. Finally, content was productized as a differentiated physician newsletter, supported by drug advertising.

Vice President of Product Management

Pharmaspectra, now part of IQVIA, New York, NY Q3 2017 – Q3 2019

Pharmaspectra, formerly Medmeme and currently part of IQVIA, provided KOL identification & profiling, share of voice, clinical trials search, and medical meeting abstracts search solutions.

I led product management taking all legacy products and modernizing them. I also led the development of a drug labeling intelligence solution. The company was sold to private equity before its completion.

I also led consulting and product implementation/integration engagements with large pharma clients including engagements on which KOLs, journals and medical meetings to choose in order to disseminate core messages, what core messages to lead with based on analysis of RWE and existing research trends, and how to integrate with the CRMs used by MSLs to optimize medical comms.

Managing Director of Partnering

Biotechnology Innovation Organization (BIO), Washington, D.C. Q3 2013 – Q2 2017

Led software product management, customer service, logistics and business development for the primary revenue generating division for the world’s largest biotech trade organization. This led to a 50% increase in revenue over 4.5 years, from $20M to $30M.

• Created and launched BIO’s new partnering system, enduring from 2015 – 2025. The system set partnering records for every BIO event and served as the basis for BIO’s current system.
• Launched and shepherded the first 2 years of BIO’s (now) 2nd-largest event product, BIO Partnering @ JPM.
• Created the SPARK Showcase event at BIO Investor Forum through a collaboration with Stanford.
• Organized and led numerous marketing campaigns and webinars including the wildly popular JPM Receptions webinars, providing the basis for BIO’s current Guide to JPM app.
• Designed and implemented numerous new customer service workflows and procedures.
• Served as sales engineer in all large pharma sponsorship sales calls and meetings.
• Managed large pharma partnering campaigns for all top-10 pharmas, which included direct interactions with VP and SVP level.

Sr. Product Manager

Thomson Reuters Life Sciences, now Clarivate, Philadelphia, PA Q3 2008 – Q3 2013

Created and launched Clarivate’s key and still current life science intelligence platforms and one product

• Created and launched the Cortellis platform and the Cortellis API, which still powers Clarivate’s Life Science products and drives over $100M in annual revenue today.
• Created and launched the Cortellis for Clinical Trials Intelligence, driving over $12M in revenue today.
• Created the Event Transcript content set within Cortellis by brokering a deal with Thomson Financial.

Product Manager, Philadelphia, PA

Liquent, now part of Perceptive Q3 2005 – Q3 2008

Led product management for pharmaceutical regulatory software solutions related to regulatory information management, eCTD management, regulatory publishing, and regulatory document management. This product portfolio generated $40M of revenue.

MS, Information Science The Pennsylvania State University

BS, Electrical Engineering The Pennsylvania State University